Literature DB >> 24166954

Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regulated exopolysaccharide colanic acid.

Helen Miajlovic1, Niamh M Cooke, Gary P Moran, Thomas R F Rogers, Stephen G Smith.   

Abstract

Extraintestinal Escherichia coli (ExPEC) organisms are the leading cause of Gram-negative bacterial bloodstream infections. These bacteria adapt to survival in the bloodstream through expression of factors involved in scavenging of nutrients and resisting the killing activity of serum. In this study, the transcriptional response of a prototypic ExPEC strain (CFT073) to human serum was investigated. Resistance of CFT073 to the bactericidal properties of serum involved increased expression of envelope stress regulators, including CpxR, σE, and RcsB. Many of the upregulated genes induced by active serum were regulated by the Rcs two-component system. This system is triggered by envelope stress such as changes to cell wall integrity. RcsB-mediated serum resistance was conferred through induction of the exopolysaccharide colanic acid. Production of this exopolysaccharide may be protective while cell wall damage caused by serum components is repaired.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24166954      PMCID: PMC3911843          DOI: 10.1128/IAI.00800-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1.

Authors:  Nemani V Prasadarao; Anna M Blom; Bruno O Villoutreix; Linette C Linsangan
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

3.  Role of avian pathogenic Escherichia coli virulence factors in bacterial interaction with chicken heterophils and macrophages.

Authors:  Melha Mellata; Maryvonne Dho-Moulin; Charles M Dozois; Roy Curtiss; Brigitte Lehoux; John M Fairbrother
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

4.  A complementation analysis of the restriction and modification of DNA in Escherichia coli.

Authors:  H W Boyer; D Roulland-Dussoix
Journal:  J Mol Biol       Date:  1969-05-14       Impact factor: 5.469

Review 5.  Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.

Authors:  M A Mulvey; J D Schilling; J J Martinez; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 6.  Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem.

Authors:  Thomas A Russo; James R Johnson
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

7.  Genome-wide analyses revealing a signaling network of the RcsC-YojN-RcsB phosphorelay system in Escherichia coli.

Authors:  Daisuke Hagiwara; Masahito Sugiura; Taku Oshima; Hirotada Mori; Hirofumi Aiba; Takafumi Yamashino; Takeshi Mizuno
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

8.  Activation of the RcsC/YojN/RcsB phosphorelay system attenuates Salmonella virulence.

Authors:  Chakib Mouslim; Mónica Delgado; Eduardo A Groisman
Journal:  Mol Microbiol       Date:  2004-10       Impact factor: 3.501

9.  DegS is necessary for virulence and is among extraintestinal Escherichia coli genes induced in murine peritonitis.

Authors:  Peter Redford; Paula L Roesch; Rodney A Welch
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone.

Authors:  Minh-Duy Phan; Kate M Peters; Sohinee Sarkar; Samuel W Lukowski; Luke P Allsopp; Danilo Gomes Moriel; Maud E S Achard; Makrina Totsika; Vikki M Marshall; Mathew Upton; Scott A Beatson; Mark A Schembri
Journal:  PLoS Genet       Date:  2013-10-03       Impact factor: 5.917

View more
  27 in total

1.  Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.

Authors:  Marta Putrinš; Karin Kogermann; Eliisa Lukk; Markus Lippus; Vallo Varik; Tanel Tenson
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

2.  Envelope Stress and Regulation of the Salmonella Pathogenicity Island 1 Type III Secretion System.

Authors:  Alexander D Palmer; James M Slauch
Journal:  J Bacteriol       Date:  2020-08-10       Impact factor: 3.490

3.  Genomic and Transcriptomic Analysis of Escherichia coli Strains Associated with Persistent and Transient Bovine Mastitis and the Role of Colanic Acid.

Authors:  John D Lippolis; Devin B Holman; Brian W Brunelle; Tyler C Thacker; Bradley L Bearson; Timothy A Reinhardt; Randy E Sacco; Thomas A Casey
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

4.  Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice.

Authors:  Valéria Szijártó; Luis M Guachalla; Zehra C Visram; Katharina Hartl; Cecília Varga; Irina Mirkina; Jakub Zmajkovic; Adriana Badarau; Gerhild Zauner; Clara Pleban; Zoltán Magyarics; Eszter Nagy; Gábor Nagy
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

5.  Comparative Metabolic Characterization of Extraintestinal Pathogenic Escherichia coli Blood Isolates from Saudi Arabia.

Authors:  Abdulaziz Alangari; Ahmad Abu Jaffal; Abdulaziz M Alyousef; Abdullah A Alyousef
Journal:  J Trop Med       Date:  2022-05-30

6.  Host-specific induction of Escherichia coli fitness genes during human urinary tract infection.

Authors:  Sargurunathan Subashchandrabose; Tracy H Hazen; Ariel R Brumbaugh; Stephanie D Himpsl; Sara N Smith; Robert D Ernst; David A Rasko; Harry L T Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

7.  Innate immune evasion of Escherichia coli clinical strains from orthopedic implant infections.

Authors:  L Crémet; A Broquet; C Jacqueline; C Chaillou; K Asehnoune; S Corvec; N Caroff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-02       Impact factor: 3.267

8.  Kingella kingae Surface Polysaccharides Promote Resistance to Human Serum and Virulence in a Juvenile Rat Model.

Authors:  Vanessa L Muñoz; Eric A Porsch; Joseph W St Geme
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

9.  OXA-181-Producing Extraintestinal Pathogenic Escherichia coli Sequence Type 410 Isolated from a Dog in Portugal.

Authors:  Michael Brilhante; Juliana Menezes; Adriana Belas; Claudia Feudi; Stefan Schwarz; Constança Pomba; Vincent Perreten
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

10.  Colanic Acid Intermediates Prevent De Novo Shape Recovery of Escherichia coli Spheroplasts, Calling into Question Biological Roles Previously Attributed to Colanic Acid.

Authors:  Dev K Ranjit; Kevin D Young
Journal:  J Bacteriol       Date:  2016-03-31       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.